RU94015171A - Derivatives of benzimidazole and a mixture of their isomers or individual isomers and their acid-additive salt - Google Patents
Derivatives of benzimidazole and a mixture of their isomers or individual isomers and their acid-additive saltInfo
- Publication number
- RU94015171A RU94015171A RU94015171/04A RU94015171A RU94015171A RU 94015171 A RU94015171 A RU 94015171A RU 94015171/04 A RU94015171/04 A RU 94015171/04A RU 94015171 A RU94015171 A RU 94015171A RU 94015171 A RU94015171 A RU 94015171A
- Authority
- RU
- Russia
- Prior art keywords
- carbon atoms
- alkyl
- unsubstituted
- isomers
- disubstituted
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 2
- 150000003839 salts Chemical class 0.000 title claims 2
- 239000011780 sodium chloride Substances 0.000 title claims 2
- 239000000654 additive Substances 0.000 title 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
- 125000004432 carbon atoms Chemical group C* 0.000 claims 18
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- BNBQRQQYDMDJAH-UHFFFAOYSA-N Benzodioxan Chemical compound C1=CC=C2OCCOC2=C1 BNBQRQQYDMDJAH-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 125000004442 acylamino group Chemical group 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 claims 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 1
- -1 aminosulfonylamino group Chemical group 0.000 claims 1
- 230000003042 antagnostic Effects 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 150000008641 benzimidazolones Chemical class 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims 1
Claims (1)
где R1 и R2 одинаковы или различны и означают атом водорода, атом галогена, трифторметил, алкил с 1 - 6 атомами углерода, алкокси с 1 - 6 атомами углерода, алкилтио с 1 - 6 атомами углерода, ацил с 1 - 6 атомами углерода, карбоксил, алкоксикарбонил с 1 - 6 атомами углерода, гидрокси, нитро-группу или амино-группу, незамещенную или N-моно- или дизамещенную алкилом с 1 - 4 атомами углерода, ациламино с 1 - 6 атомами углерода, алкоксикарбониламино с 1 - 6 атомами углерода, карбамоил, незамещенный или N-моно- или дизамещенный алкилом с 1 - 4 атомами углерода, циано, алкилсульфинил с 1 - 6 атомами углерода, аминосульфонил, незамещенный или N-моно- или дизамещенный алкилом с 1 - 4 атомами углерода, или аминосульфониламино-группу, незамещенную или N-моно- или дизамещенную алкилом с 1 - 4 атомами углерода; R3 - атом водорода, алкил с 1 - 6 атомами углерода, алкенил с 2 - 6 атомами углерода или алкинил с 2 - 6 атомами углерода; А - группа -CO- или -CONH-, или же А отсутствует; В - неразветвленный или разветвленный, насыщенный или ненасыщенный алкил с 2 - 6 атомами углерода; m и n независимо друг от друга означают целое число 1 - 3; R4 - фенил, нафтил или бензодиоксан, незамещенные или замещенные по меньшей мере одним заместителем из группы, включающей атом галогена, трифторметил, циано, алкокси с 1 - 3 атомами углерода и алкил с 1 - 4 атомами углерода, смеси их изомеров или индивидуальные изомеры и их кислотно-аддитивные соли, которые обладают биологической активностью, в частности могут применяться в качестве антагониста рецептора 5-НТ1 А и 5-НТ2.The object of the invention are benzimidazolone derivatives of General formula (I)
where R 1 and R 2 are the same or different and mean a hydrogen atom, a halogen atom, trifluoromethyl, alkyl with 1-6 carbon atoms, alkoxy with 1-6 carbon atoms, alkylthio with 1-6 carbon atoms, acyl with 1-6 carbon atoms , carboxyl, alkoxycarbonyl with 1-6 carbon atoms, hydroxy, nitro group or amino group, unsubstituted or N-mono- or disubstituted with alkyl with 1-4 carbon atoms, acylamino with 1-6 carbon atoms, alkoxycarbonylamino with 1-6 carbon atoms, carbamoyl, unsubstituted or N-mono- or disubstituted by alkyl with 1-4 carbon atoms, cyano, alkyl sulphinyl with 1 to 6 carbon atoms, aminosulfonyl, unsubstituted or N-mono- or disubstituted with alkyl with 1 to 4 carbon atoms, or an aminosulfonylamino group, unsubstituted with or N-mono- or disubstituted with alkyl with 1 to 4 carbon atoms; R 3 is a hydrogen atom, alkyl with 1 to 6 carbon atoms, alkenyl with 2 to 6 carbon atoms or alkynyl with 2 to 6 carbon atoms; A - group -CO- or -CONH-, or A is absent; B - unbranched or branched, saturated or unsaturated alkyl with 2-6 carbon atoms; m and n independently of each other mean an integer of 1 - 3; R 4 is phenyl, naphthyl or benzodioxane, unsubstituted or substituted by at least one substituent from the group including halogen atom, trifluoromethyl, cyano, alkoxy with 1 to 3 carbon atoms and alkyl with 1 to 4 carbon atoms, mixtures of their isomers or individual isomers and their acid addition salts, which have biological activity, in particular, can be used as an antagonist of the 5-HT 1 A and 5-HT 2 receptor.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI91A002118 | 1991-07-30 | ||
ITM191A002118 | 1991-07-30 | ||
ITMI912118A IT1251144B (en) | 1991-07-30 | 1991-07-30 | BENZIMIDAZOLONE DERIVATIVES |
PCT/IT1992/000088 WO1993003016A1 (en) | 1991-07-30 | 1992-07-30 | Benzimidazolone derivatives as 5-ht1a and 5-ht2 antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94015171A true RU94015171A (en) | 1995-09-10 |
RU2096411C1 RU2096411C1 (en) | 1997-11-20 |
Family
ID=11360463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU9294015171A RU2096411C1 (en) | 1991-07-30 | 1992-07-30 | Derivatives of benzimidazolone, mixture of their isomers or their acid additive salts as antagonist of receptor 5htia and 5ht2 |
Country Status (32)
Country | Link |
---|---|
US (1) | US5576318A (en) |
EP (1) | EP0526434B1 (en) |
JP (1) | JP2989667B2 (en) |
KR (1) | KR100263495B1 (en) |
AT (1) | ATE191910T1 (en) |
AU (1) | AU665366B2 (en) |
CA (1) | CA2114542C (en) |
CZ (1) | CZ281511B6 (en) |
DE (1) | DE69230926T2 (en) |
DK (1) | DK0526434T3 (en) |
EE (1) | EE03070B1 (en) |
ES (1) | ES2144412T3 (en) |
FI (1) | FI111460B (en) |
GR (1) | GR3033947T3 (en) |
HK (1) | HK1010725A1 (en) |
HU (2) | HUT70195A (en) |
IE (1) | IE922464A1 (en) |
IL (1) | IL102665A (en) |
IT (1) | IT1251144B (en) |
MX (1) | MX9204139A (en) |
NO (1) | NO304070B1 (en) |
NZ (1) | NZ243777A (en) |
PH (1) | PH30998A (en) |
PL (1) | PL171329B1 (en) |
PT (1) | PT526434E (en) |
RU (1) | RU2096411C1 (en) |
SG (1) | SG52407A1 (en) |
SK (1) | SK279292B6 (en) |
TW (1) | TW209862B (en) |
UA (1) | UA42684C2 (en) |
WO (1) | WO1993003016A1 (en) |
ZA (1) | ZA925682B (en) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1251144B (en) * | 1991-07-30 | 1995-05-04 | Boehringer Ingelheim Italia | BENZIMIDAZOLONE DERIVATIVES |
US5266571A (en) * | 1992-01-09 | 1993-11-30 | Amer Moh Samir | Treatment of hemorrhoids with 5-HT2 antagonists |
SE9201138D0 (en) * | 1992-04-09 | 1992-04-09 | Astra Ab | NOVEL PHTHALIMIDOALKYL PIPERAZINES |
DK148392D0 (en) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Heterocyclic Compounds |
PT689536E (en) * | 1993-03-16 | 2001-11-30 | Pfizer | NAFTALENE DERIVATIVES |
JP3719612B2 (en) * | 1993-06-14 | 2005-11-24 | 塩野義製薬株式会社 | Urea derivatives containing heterocycles |
ZA954688B (en) * | 1994-06-08 | 1996-01-29 | Lundbeck & Co As H | Serotonin 5-HT1A and dopamin D2 receptor ligands |
PT765320E (en) * | 1994-06-14 | 2002-02-28 | Pfizer | BENZIMIDAZOLONE DERIVATIVES WITH CENTRAL DOPAMINERGIC ACTIVITY |
DK0775118T3 (en) * | 1994-08-05 | 2003-09-29 | Pfizer | Benzimidazole derivatives having dopaminergic activity |
US5883094A (en) * | 1995-04-24 | 1999-03-16 | Pfizer Inc. | Benzimidazolone derivatives with central dopaminergic activity |
US5889010A (en) * | 1995-05-18 | 1999-03-30 | Pfizer Inc. | Benzimidazole derivatives having dopaminergic activity |
WO1997016187A1 (en) * | 1995-10-31 | 1997-05-09 | Merck & Co., Inc. | Muscarine antagonists |
WO1999065887A1 (en) * | 1998-06-15 | 1999-12-23 | American Home Products Corporation | Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
US6376494B1 (en) | 1998-06-15 | 2002-04-23 | American Home Products Corporation | Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
AR022303A1 (en) | 1999-01-22 | 2002-09-04 | Lundbeck & Co As H | DERIVATIVES OF PIPERIDINE, TETRAHYDROPIRIDINE AND PIPERAZINE, ITS PREPARATION AND USE |
IT1313625B1 (en) * | 1999-09-22 | 2002-09-09 | Boehringer Ingelheim Italia | BENZIMIDAZOLONIC DERIVATIVES WITH MIXED AFFINITY FOR DYEROTONIN AND DOPAMIN RECEPTORS. |
US6521623B1 (en) | 2000-09-19 | 2003-02-18 | Boehringer Ingelheim Pharma Kg | N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
US6586435B2 (en) | 2000-09-19 | 2003-07-01 | Boehringer Ingelheim Pharma Kg | Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
JP5062938B2 (en) * | 2000-09-19 | 2012-10-31 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | Novel N, N'-disubstituted benzimidazolone derivatives having affinity for serotonin receptors and dopamine receptors |
JP5062939B2 (en) * | 2000-09-19 | 2012-10-31 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | Novel N, N'-disubstituted benzimidazolone derivatives showing affinity for serotonin receptors and dopamine receptors |
WO2003007956A1 (en) | 2001-07-20 | 2003-01-30 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder |
US7183410B2 (en) * | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
AU2002331361B2 (en) * | 2001-08-02 | 2008-06-05 | Sprout Pharmaceuticals, Inc. | Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments |
US20030060475A1 (en) * | 2001-08-10 | 2003-03-27 | Boehringer Ingelheim Pharma Kg | Method of using flibanserin for neuroprotection |
DE10138273A1 (en) * | 2001-08-10 | 2003-02-27 | Boehringer Ingelheim Pharma | Medicines with neuroprotective effects |
UA78974C2 (en) * | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
WO2003097058A1 (en) * | 2002-05-22 | 2003-11-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New pharmaceutical compositions containing flibanserin polymorph a |
US20040048877A1 (en) * | 2002-05-22 | 2004-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions containing flibanserin |
RS20050195A (en) * | 2002-09-17 | 2007-08-03 | Warner Lambert Company Llc., | Heterocyclic substituted piperazines for the treatment of schizophrenia |
WO2005021539A1 (en) * | 2003-09-03 | 2005-03-10 | Pfizer Japan, Inc. | Benzimidazolone compounds having 5-ht4 receptor agonistic activity |
WO2005102342A1 (en) * | 2004-04-22 | 2005-11-03 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions for the treatment of sexual disorders ii |
US20050239798A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the treatment of premenstrual and other female sexual disorders |
US7737163B2 (en) * | 2004-06-15 | 2010-06-15 | Pfizer Inc. | Benzimidazolone carboxylic acid derivatives |
EA200801608A1 (en) * | 2004-06-15 | 2008-10-30 | Пфайзер Инк. | DERIVATIVES OF BENZIMIDAZOLONIC CARBONIC ACID |
US20060014757A1 (en) * | 2004-07-14 | 2006-01-19 | Boehringer Ingelheim Pharmaceuticals | Method for the treatment of anorexia nervosa |
US20060025420A1 (en) * | 2004-07-30 | 2006-02-02 | Boehringer Ingelheimn International GmbH | Pharmaceutical compositions for the treatment of female sexual disorders |
WO2006024471A1 (en) * | 2004-09-03 | 2006-03-09 | Boehringer Ingelheim International Gmbh | Method for the treatment of attention deficit hyperactivity disorder |
NZ556627A (en) * | 2005-02-22 | 2010-09-30 | Pfizer | Oxyindole derivatives as 5HT4 receptor agonists |
WO2006096439A2 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases |
JP2008531714A (en) * | 2005-03-04 | 2008-08-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Pharmaceutical composition for the treatment and / or prevention of anxiety disorders |
WO2006096435A1 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of depression |
WO2006119884A2 (en) * | 2005-05-06 | 2006-11-16 | Boehringer Ingelheim International Gmbh | Method for the treatment of drug abuse with flibanserin |
EP1888071A1 (en) * | 2005-05-19 | 2008-02-20 | Boehringer Ingelheim International GmbH | Method for the treatment of drug-induced sexual dysfunction |
EP1888070A1 (en) * | 2005-05-19 | 2008-02-20 | Boehringer Ingelheim International GmbH | Method for the treatment of sexual dysfunctions due to medical conditions |
US8227476B2 (en) | 2005-08-03 | 2012-07-24 | Sprout Pharmaceuticals, Inc. | Use of flibanserin in the treatment of obesity |
US7790726B2 (en) * | 2005-08-16 | 2010-09-07 | Chemocentryx, Inc. | Monocyclic and bicyclic compounds and methods of use |
US20070123540A1 (en) * | 2005-10-29 | 2007-05-31 | Angelo Ceci | Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
JP2009513604A (en) * | 2005-10-29 | 2009-04-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Benzimidazolone derivatives for the treatment of premenstrual disorders and other female sexual disorders |
US20070105869A1 (en) * | 2005-11-08 | 2007-05-10 | Stephane Pollentier | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
EP1988897A1 (en) * | 2006-02-20 | 2008-11-12 | Boehringer Ingelheim International GmbH | Benzimidazolone derivatives for the treatment of urinary incontinence |
JPWO2007099828A1 (en) * | 2006-02-23 | 2009-07-16 | 塩野義製薬株式会社 | Nitrogen-containing heterocyclic derivatives substituted with cyclic groups |
CA2642368A1 (en) * | 2006-02-28 | 2007-09-07 | Boehringer Ingelheim International Gmbh | Treatment of prevention of valvular heart disease with flibanserin |
RS54398B1 (en) * | 2006-05-09 | 2016-04-28 | Sprout Pharmaceuticals, Inc. | Use of flibanserin for the treatment of post-menopausal sexual desire disorders |
JP2009541443A (en) | 2006-06-30 | 2009-11-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Flibanserin for the treatment of urinary incontinence and related diseases |
WO2008006838A1 (en) * | 2006-07-14 | 2008-01-17 | Boehringer Ingelheim International Gmbh | Use of flibanserin for the treatment of sexual disorders in females |
KR20090042967A (en) | 2006-08-14 | 2009-05-04 | 베링거 인겔하임 인터내셔날 게엠베하 | Formulations of flibanserin and method for manufacturing the same |
CL2007002214A1 (en) | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | PHARMACEUTICAL COMPOSITION IN THE FORM OF COMPRESSED, WHERE AT LEAST THE LENGTH OF THE COMPRESSED IN THE PREVIOUS STATE OF THE APPLICATION IS AT LEAST 7/12 OF THE PILOR DIAMETER OF THE PATIENT AND AFTER INGERING IT IN THE FOOD STATE, THE LENGTH OF THE COMP |
EA200900270A1 (en) | 2006-08-25 | 2009-08-28 | Бёрингер Ингельхайм Интернациональ Гмбх | SYSTEMS OF ADJUSTABLE GRINDING AND METHOD OF THEIR PREPARATION |
JP2010513390A (en) | 2006-12-20 | 2010-04-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Sulfated benzimidazolone derivatives with mixed serotonin receptor affinity |
WO2008090742A1 (en) * | 2007-01-23 | 2008-07-31 | National University Corporation Hokkaido University | Non-human animal for eye disease model |
JP5514716B2 (en) | 2007-05-11 | 2014-06-04 | コリア・リサーチ・インスティテュート・オブ・ケミカル・テクノロジー | Imidazole derivative having arylpiperidine substituent, method for producing the same, and pharmaceutical composition containing the same |
UY31335A1 (en) | 2007-09-12 | 2009-04-30 | VASOMOTOR SYMPTOMS TREATMENT | |
EP2238117A1 (en) * | 2008-01-24 | 2010-10-13 | NeuroSearch A/S | 4-phenyl-piperazin-1-yl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
EP2090297A1 (en) | 2008-02-13 | 2009-08-19 | Boehringer Ingelheim International GmbH | Formulations of flibanserin |
CA2686480A1 (en) * | 2008-12-15 | 2010-06-15 | Boehringer Ingelheim International Gmbh | New salts |
WO2010146595A2 (en) * | 2009-06-16 | 2010-12-23 | Symed Labs Limited | Novel polymorphs of flibanserin hydrochloride |
BRPI1003506B1 (en) | 2010-09-24 | 2019-12-03 | Ache Int Bvi Ltd | alkyl-piperazine-phenyl-4 (3h) quinazolinone compound and use of the alkyl-piperazine-phenyl-4 (3h) quinazolinone compound associated with 5-ht1a and 5-ht2a serotonergic receptors |
EP2906221B1 (en) | 2012-10-11 | 2019-05-15 | Southern Research Institute | Urea and amide derivatives of aminoalkylpiperazines and use thereof |
CN104926734B (en) * | 2015-07-07 | 2017-04-05 | 苏州立新制药有限公司 | The preparation method of flibanserin |
WO2017076213A1 (en) * | 2015-11-02 | 2017-05-11 | 苏州旺山旺水生物医药有限公司 | Benzimidazole compound, preparation method thereof and usage |
WO2017076356A1 (en) * | 2015-11-05 | 2017-05-11 | 苏州晶云药物科技有限公司 | Novel crystal form of flibaserin, and preparation method therefor |
CN106749038A (en) * | 2015-11-25 | 2017-05-31 | 山东诚创医药技术开发有限公司 | A kind of preparation method of flibanserin |
CN106866546A (en) * | 2015-12-10 | 2017-06-20 | 常州爱诺新睿医药技术有限公司 | Solid dispersions of flibanserin or its pharmaceutically acceptable salt and pharmaceutic adjuvant and preparation method thereof |
CN113683570A (en) | 2016-01-31 | 2021-11-23 | 孟晓明 | New crystal form of flibanserin, preparation method and application thereof |
WO2017133337A1 (en) * | 2016-02-02 | 2017-08-10 | 深圳市塔吉瑞生物医药有限公司 | Substituted benzimidazolone compound and composition comprising the same |
CN107235913B (en) * | 2016-03-29 | 2020-07-10 | 苏州科伦药物研究有限公司 | Method for efficiently manufacturing high-quality flibanserin on industrial scale |
CN106866582A (en) * | 2017-01-10 | 2017-06-20 | 广州隽沐生物科技有限公司 | A kind of preparation method of flibanserin intermediate |
HU231283B1 (en) | 2018-08-01 | 2022-09-28 | Richter Gedeon Nyrt | Process for the multistep continuous-flow preparation of flibanserin |
EP4308119A1 (en) * | 2021-03-19 | 2024-01-24 | Centre National de la Recherche Scientifique | <sup2/>? <sub2/>?7?applications of biased ligands of the serotonin 5-htreceptor for the treatment of pain, multiple sclerosis and the control of thermoregulation |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3406178A (en) * | 1964-02-04 | 1968-10-15 | Monsanto Chem Australia Ltd | Preparation of 2-substituted benzimidazoles |
US3362956A (en) * | 1965-08-19 | 1968-01-09 | Sterling Drug Inc | 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines |
YU39992B (en) * | 1976-04-02 | 1985-06-30 | Janssen Pharmaceutica Nv | Process for obtaining new piperazine and piperidine derivatives |
FI791926A (en) * | 1978-06-20 | 1979-12-21 | Synthelabo | PHENYLPIPERAZINE DERIVATIVES |
IT1176613B (en) * | 1984-08-14 | 1987-08-18 | Ravizza Spa | PHARMACOLOGICALLY ACTIVE PIPERAZINIC DERIVATIVES AND PROCESS FOR THEIR PREPARATION |
IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
GB8607294D0 (en) * | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
NL8601494A (en) * | 1985-06-22 | 1987-01-16 | Sandoz Ag | THIAZOLS, THEIR PREPARATIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. |
GB8601160D0 (en) * | 1986-01-17 | 1986-02-19 | Fujisawa Pharmaceutical Co | Heterocyclic compounds |
US5036088A (en) * | 1986-06-09 | 1991-07-30 | Pfizer Inc. | Antiallergy and antiinflammatory agents, compositions and use |
JPH0784462B2 (en) * | 1986-07-25 | 1995-09-13 | 日清製粉株式会社 | Benzimidazole derivative |
US4954503A (en) * | 1989-09-11 | 1990-09-04 | Hoechst-Roussel Pharmaceuticals, Inc. | 3-(1-substituted-4-piperazinyl)-1H-indazoles |
IT1251144B (en) * | 1991-07-30 | 1995-05-04 | Boehringer Ingelheim Italia | BENZIMIDAZOLONE DERIVATIVES |
-
1991
- 1991-07-30 IT ITMI912118A patent/IT1251144B/en active IP Right Grant
-
1992
- 1992-07-15 MX MX9204139A patent/MX9204139A/en unknown
- 1992-07-28 IL IL10266592A patent/IL102665A/en not_active IP Right Cessation
- 1992-07-28 TW TW081105974A patent/TW209862B/zh not_active IP Right Cessation
- 1992-07-29 ZA ZA925682A patent/ZA925682B/en unknown
- 1992-07-29 PH PH44739A patent/PH30998A/en unknown
- 1992-07-29 IE IE246492A patent/IE922464A1/en not_active IP Right Cessation
- 1992-07-30 SK SK101-94A patent/SK279292B6/en unknown
- 1992-07-30 DK DK92830427T patent/DK0526434T3/en active
- 1992-07-30 ES ES92830427T patent/ES2144412T3/en not_active Expired - Lifetime
- 1992-07-30 EP EP92830427A patent/EP0526434B1/en not_active Expired - Lifetime
- 1992-07-30 AT AT92830427T patent/ATE191910T1/en active
- 1992-07-30 AU AU24275/92A patent/AU665366B2/en not_active Expired
- 1992-07-30 DE DE69230926T patent/DE69230926T2/en not_active Expired - Lifetime
- 1992-07-30 PL PL92302163A patent/PL171329B1/en unknown
- 1992-07-30 HU HU9400255A patent/HUT70195A/en unknown
- 1992-07-30 UA UA94005462A patent/UA42684C2/en unknown
- 1992-07-30 RU RU9294015171A patent/RU2096411C1/en active
- 1992-07-30 JP JP50345393A patent/JP2989667B2/en not_active Expired - Lifetime
- 1992-07-30 SG SG1996004034A patent/SG52407A1/en unknown
- 1992-07-30 KR KR1019940700293A patent/KR100263495B1/en not_active IP Right Cessation
- 1992-07-30 WO PCT/IT1992/000088 patent/WO1993003016A1/en active IP Right Grant
- 1992-07-30 PT PT92830427T patent/PT526434E/en unknown
- 1992-07-30 CZ CZ94170A patent/CZ281511B6/en not_active IP Right Cessation
- 1992-07-30 CA CA002114542A patent/CA2114542C/en not_active Expired - Lifetime
- 1992-07-30 NZ NZ243777A patent/NZ243777A/en unknown
-
1994
- 1994-01-28 FI FI940420A patent/FI111460B/en not_active IP Right Cessation
- 1994-01-28 NO NO940306A patent/NO304070B1/en not_active IP Right Cessation
- 1994-03-23 US US08/216,742 patent/US5576318A/en not_active Expired - Lifetime
- 1994-11-23 EE EE9400396A patent/EE03070B1/en unknown
-
1995
- 1995-06-20 HU HU95P/P00292P patent/HU211256A9/en unknown
-
1998
- 1998-10-21 HK HK98111444A patent/HK1010725A1/en not_active IP Right Cessation
-
2000
- 2000-07-12 GR GR20000401632T patent/GR3033947T3/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94015171A (en) | Derivatives of benzimidazole and a mixture of their isomers or individual isomers and their acid-additive salt | |
RU93005057A (en) | PHARMACEUTICAL COMPOUNDS, THYENOBENZODIAZEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION, PHARMOCOMPOSITION AND THEIR USE | |
EA200000481A1 (en) | DERIVATIVES OF HYDROXAMIC ACID AS INHIBITORS OF MATRIX METALLOPROTEASIS (MPM) | |
RU2004130488A (en) | Pyrimidine derivatives | |
RU2342367C2 (en) | Non-nucleozide inhibitors i of reverse transcriptase, intended for treatment of hiv-mediated diseases | |
DK0628311T3 (en) | Xanthine derivatives as antidepressants | |
RU92004429A (en) | DERIVATIVES 2- (1-PIPERASINIL) -4-PHENYL-CYCLO-ALKANOPYRIDINE | |
RU98108602A (en) | Succinimide and maleimide cytokine inhibitors | |
ES2098421T3 (en) | ACID ANILIDE DERIVATIVES AND THEIR USE FOR THE FIGHT AGAINST BOTRYTIS. | |
RU94004975A (en) | Derivatives of a substituted heterocyclic phenyl-cyclohexane-carboxylic acid, a mixture of their isomers or separate isomers and their salt | |
KR850007975A (en) | Method for preparing 6-chlorobenzazolyloxyacetamide | |
RU96123116A (en) | AMIDES N-SULPHONYL- AND N-SULPHONYLAMINO ACIDS AS MICROBICIDES | |
DE69317439D1 (en) | Azoxycyanbenzene derivatives | |
KR900004658A (en) | Disubstituted benzylamine, preparation method thereof, use thereof as medicament and synthesis agent thereof | |
RU2004101964A (en) | SUBSTITUTED Benzopyran derivatives against arrhythmias | |
KR890011832A (en) | Aminoguanidine derivatives, and inhibitors of Maillard reaction containing them as active ingredients | |
PT97991A (en) | PROCESS FOR THE PREPARATION OF 2- (AMINOALQUIL) -5- (ARILALQUIL) -1,3-DIOXANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
RU93058270A (en) | DERIVATIVES OF SULFONILMOCHEVINY, METHOD OF THEIR PRODUCTION AND THEIR APPLICATION | |
KR880000388A (en) | Leukotriene antagonist | |
EA200400847A1 (en) | IMIDAZOZHINOLINA DERIVATIVES | |
RU94008857A (en) | Derivatives of a substituted heterocyclic phenyl-cyclohexane-carboxylic acid, a mixture of their isomers or separate isomers and their salt | |
ES2059550T3 (en) | DERIVATIVES FROM BENCIMIDAZOLA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS. | |
KR930021629A (en) | Piperazine Derivatives | |
SU1573021A1 (en) | 14alpha-oxy-7,8-methylene dioxy alloberban posessing antidepressive activity | |
PT1038863E (en) | A process for preparing a pharmaceutical composition for the preparation of a medicament for use in the treatment of premature ejaculation. |